Combinatorial Effects of Azacitidine and Trametinib on NRAS-Mutated Melanoma

Exposure to trametinib and azacitidine prevented development of trametinib resistance in NRAS-mutated human melanoma cells in vitro. Azacitidine acted synergistically with trametinib to inhibit the growth of trametinib-resistant melanoma cells.